Skip to main content
. 2021 Nov;10(11):2921–2928. doi: 10.21037/tp-21-283

Table 3. Treatment, hospital duration and outcome.

Variables All patients (n=74) Immune-mediated (n=7) Liver dysfunction (n=4) Cardiovascular causes (n=3) Miscellaneous (infection and other conditions) (n=12) IPH (n=48) P value
Blood transfusion 53 (71.6) 6 (85.7) 4 (100.0) 1 (33.3) 7 (58.3) 35 (72.9) 0.280
IVIG 23 (31.1) 4 (66.7) 2 (50.0) 1 (33.3) 6 (50.0) 9 (18.8) 0.013
Oxygen treatment 38 (51.4) 6 (85.7) 4 (100.0) 2 (66.7) 11 (91.7) 15 (31.3) <0.001
Mechanical ventilation 25 (33.8) 4 (66.7) 3 (60.0) 2 (66.7) 10 (83.3) 6 (12.5) <0.001
Hospital length of stay, days 13±1.5 14.3±12.7 3.8±2.2 12.3±2.5 19.7±21.7 11.9±9.7 0.145
In hospital mortality 19 (25.7) 3 (42.9) 4 (100.0) 2 (66.7) 9 (75.0) 1 (2.1) <0.001